IL121647A0 - Pharmaceutical compositions for the treatment of ocular inflammations comprising dexamethasone palmitate - Google Patents

Pharmaceutical compositions for the treatment of ocular inflammations comprising dexamethasone palmitate

Info

Publication number
IL121647A0
IL121647A0 IL12164797A IL12164797A IL121647A0 IL 121647 A0 IL121647 A0 IL 121647A0 IL 12164797 A IL12164797 A IL 12164797A IL 12164797 A IL12164797 A IL 12164797A IL 121647 A0 IL121647 A0 IL 121647A0
Authority
IL
Israel
Prior art keywords
treatment
pharmaceutical compositions
dexamethasone palmitate
ocular inflammations
inflammations
Prior art date
Application number
IL12164797A
Other versions
IL121647A (en
Original Assignee
Pharmateam Dev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmateam Dev Ltd filed Critical Pharmateam Dev Ltd
Priority to IL12164797A priority Critical patent/IL121647A/en
Publication of IL121647A0 publication Critical patent/IL121647A0/en
Priority to PCT/IL1998/000411 priority patent/WO1999011270A1/en
Priority to AU88839/98A priority patent/AU8883998A/en
Priority to CA002300850A priority patent/CA2300850A1/en
Priority to EP98940536A priority patent/EP1009409A1/en
Priority to JP2000508372A priority patent/JP2001514228A/en
Priority to CN98809486A priority patent/CN1271288A/en
Publication of IL121647A publication Critical patent/IL121647A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL12164797A 1997-08-28 1997-08-28 Pharmaceutical compositions for the treatment of ocular inflammation comprising dexamethasone palmitate IL121647A (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IL12164797A IL121647A (en) 1997-08-28 1997-08-28 Pharmaceutical compositions for the treatment of ocular inflammation comprising dexamethasone palmitate
PCT/IL1998/000411 WO1999011270A1 (en) 1997-08-28 1998-08-26 Pharmaceutical compositions for the treatment of ocular inflammations comprising dexamethasone palmitate
AU88839/98A AU8883998A (en) 1997-08-28 1998-08-26 Pharmaceutical compositions for the treatment of ocular inflammations comprisingdexamethasone palmitate
CA002300850A CA2300850A1 (en) 1997-08-28 1998-08-26 Pharmaceutical compositions for the treatment of ocular inflammations comprising dexamethasone palmitate
EP98940536A EP1009409A1 (en) 1997-08-28 1998-08-26 Pharmaceutical compositions for the treatment of ocular inflammations comprising dexamethasone palmitate
JP2000508372A JP2001514228A (en) 1997-08-28 1998-08-26 Pharmaceutical composition for treating ocular inflammation containing dexamethasone palmitate
CN98809486A CN1271288A (en) 1997-08-28 1998-08-26 Pharmaceutical compositions for the treatment of ocular inflammations comprising dexamethasone palmitate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL12164797A IL121647A (en) 1997-08-28 1997-08-28 Pharmaceutical compositions for the treatment of ocular inflammation comprising dexamethasone palmitate

Publications (2)

Publication Number Publication Date
IL121647A0 true IL121647A0 (en) 1998-02-08
IL121647A IL121647A (en) 2001-07-24

Family

ID=11070569

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12164797A IL121647A (en) 1997-08-28 1997-08-28 Pharmaceutical compositions for the treatment of ocular inflammation comprising dexamethasone palmitate

Country Status (7)

Country Link
EP (1) EP1009409A1 (en)
JP (1) JP2001514228A (en)
CN (1) CN1271288A (en)
AU (1) AU8883998A (en)
CA (1) CA2300850A1 (en)
IL (1) IL121647A (en)
WO (1) WO1999011270A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2491313C (en) * 2002-07-15 2011-05-24 Alcon, Inc. Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use
US7767217B2 (en) * 2006-03-14 2010-08-03 Foresight Biotherapeutics Ophthalmic compositions comprising povidone-iodine
PL1864667T3 (en) * 2006-06-01 2014-01-31 Santen Sas Use of prodrugs for ocular intravitreous administration
KR101541416B1 (en) 2006-06-01 2015-08-03 산텐 에스에이에스 Use of a Steroid Prodrug for the Treatment of Disease of the Posterior Segment of the Eye
EP2229174A1 (en) * 2007-12-04 2010-09-22 Novagali Pharma S.A. Compositions comprising corticosteroid prodrug such as dexamethasone palmitate for the treatment of eye disorders
CN108434090A (en) * 2017-02-14 2018-08-24 高药品股份有限公司 Using physiology fat as the steroids ointment of base

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS609726B2 (en) * 1980-05-15 1985-03-12 株式会社 ミドリ十字 steroid preparations
JPS62270521A (en) * 1986-05-16 1987-11-24 Green Cross Corp:The Flurbiprofen preparation for ophthalmic administration
IL88076A (en) * 1987-10-28 1993-01-14 Nippon Shinyaku Co Ltd Fat emulsions as drug carriers
JPH05124965A (en) * 1991-11-06 1993-05-21 L T T Kenkyusho:Kk Nasal and bronchial disease-therapeutic agent for local application

Also Published As

Publication number Publication date
CA2300850A1 (en) 1999-03-11
EP1009409A1 (en) 2000-06-21
WO1999011270A1 (en) 1999-03-11
IL121647A (en) 2001-07-24
AU8883998A (en) 1999-03-22
JP2001514228A (en) 2001-09-11
CN1271288A (en) 2000-10-25

Similar Documents

Publication Publication Date Title
IL125735A0 (en) Pharmaceutical compositions for the treatment of glaucoma
HUP9903489A3 (en) Use of epinastine for the preparation of pharmaceutical compositions treating pain
HUP0001442A3 (en) Sulfonamide derivatives and pharmaceutical compositions containing them for the treatment of endothelin-mediated disorders
IL121170A0 (en) Compositions for the treatment of dermatological disorders
IL117957A0 (en) Pharmaceutical compositions for the treatment of impotence
AU1403199A (en) Local delivery of therapeutic agents
GB2302018B (en) Ophthalmic pharmaceutical composition
ZA983602B (en) Use of tetrahydropyridine derivatives for the preparation of drugs for the treatment of diseases which cause demyelination
PL322526A1 (en) Azathiopyrin compositions for intracolic administration
HUP9904027A3 (en) Use of p-aminophenol derivatives for the preparation of pharmaceutical compositions useful in the treatment of neurodegenerative diseases
AU6858996A (en) Pharmaceutical compositions for the treatment of infectious diseases
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
AU6114998A (en) Topical nifedipine preparations for the conservative treatment of functional pathologies of the anal canal
HUP0104963A3 (en) Compositions for the treatment of skin diseases
AU7728698A (en) Oral formulations for treatment of bacteria-induced diseases of the colon
IL121647A0 (en) Pharmaceutical compositions for the treatment of ocular inflammations comprising dexamethasone palmitate
IL121096A0 (en) Pharmaceutical compositions for the treatment of liver disease
HUP9901247A3 (en) Use of naphthimidazole-, naphthoxazole- and naphthothiazole-diones for the preparation of pharmaceutical compositions treating diseases caused by vascular function deficiency
IL120005A0 (en) Pharmaceutical compositions for the treatment of the eye
GB9510162D0 (en) Compositions for the treatment of skin conditions
HUP0003159A3 (en) The use of n-monosubstituted-3-oxo-4-aza-5alpha-androst-1-en-17betha-carboxamides for the preparation of pharmaceutical compositions
AU8242398A (en) Medicinal compositions for treating immunodeficiency diseases
IL119219A0 (en) Pharmaceutical compositions for treatment of the eyes
AU1002697A (en) Topical compositions for the treatment of skin disease
IL116548A0 (en) Pharmaceutical compositions for treatment of the eyes

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
RH1 Patent not in force